Skip to main content

Loading market data...

CI

The Cigna Group

NYSE • United states

$306.60

+$8.10

(+2.71%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

The Cigna Group (CI)

Unavailable

Quotes may be delayed

$81.02B

Market Cap

1,440,321

Volume

13.0

P/E Ratio

2.02%

Div Yield

The Cigna Group Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

10 Oct 2026

The Cigna Group reported A director or senior management change or compensation event

The Cigna Group filed an 8-K covering a director or senior management change or compensation event.

30 Sep 2026

The Cigna Group reported Regulation FD disclosure

The Cigna Group filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

30 Jul 2026

The Cigna Group filed Form 10-Q

The Cigna Group submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

30 Jul 2026

The Cigna Group reported Operating or financial results

The Cigna Group filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

13 May 2026

The Cigna Group reported Regulation FD disclosure

The Cigna Group filed an 8-K covering Regulation FD disclosure.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$6.30B

Total assets (USD)$157.08B

Total liabilities (USD)$114.17B

Shareholders' equity (USD)$42.62B

Long-term debt (USD)$39.52B

Debt due within a year (USD)$2.79B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$71.67B	$2.68B	$1.66B	$6.29	10-Q · 30 Jul 2026
Q1 2026	$68.49B	$2.36B	$1.65B	$6.26	10-Q · 30 Apr 2026
Q4 2025	$72.47B	$2.35B	$943.00M	Unavailable	10-K · 26 Feb 2026
Q3 2025	$69.75B	$2.58B	$1.97B	$6.98	10-Q · 30 Oct 2025
Q2 2025	$67.18B	$2.31B	$1.63B	$5.71	10-Q · 31 Jul 2025
Q1 2025	$65.50B	$1.97B	$1.41B	$4.85	10-Q · 2 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $338.89

10.5% upside potential

📈

Strong Buy

Unavailable

👍

Buy

13

⏸️

Hold

5

📉

Sell

0

18 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 21:50 UTC Targets range 290.00–387.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

3

Sep 2026

Neville Everett

See Remarks

Open-market sale

$284.05 per share

617 shares

1

Sep 2026

Evanko Brian C

See Remarks

Grant or award

Unavailable per share

3,113 shares

18

Aug 2026

Jones Nicole S

See Remarks

Open-market sale

$279.61 per share

2,677 shares

5

Aug 2026

Jones Nicole S

See Remarks

Option exercise

$192.02 per share

1,301 shares

4

Aug 2026

Jones Nicole S

See Remarks

Option exercise

$192.02 per share

14,045 shares

4

Aug 2026

Jones Nicole S

See Remarks

Open-market sale

$276.27 per share

19,436 shares

12

Jun 2026

Kates Jamie G

Chief Accounting Officer

Option exercise

$152.89 per share

899 shares

12

Jun 2026

Kates Jamie G

Chief Accounting Officer

Open-market sale

$298.61 per share

899 shares

1

Jun 2026

Koka Durga Prasad

EVP, Global CIO

Tax withholding

$275.53 per share

729 shares

Top Shareholders

Vanguard Group Inc

26,173,577 shares

1.61% change

12/31/2025

Blackrock, Inc.

23,438,250 shares

3.718% change

6/30/2026

Vanguard Capital Management Llc

17,276,296 shares

0.901% change

6/30/2026

State Street Corp

12,682,259 shares

3.249% change

6/30/2026

Dodge & Cox

12,173,875 shares

5.349% change

6/30/2026

Massachusetts Financial Services Co /Ma/

10,443,691 shares

-9.931% change

6/30/2026

Sanders Capital, Llc

10,144,617 shares

-1.417% change

6/30/2026

Fmr Llc

8,018,189 shares

-26.823% change

6/30/2026

Geode Capital Management, Llc

6,268,347 shares

1.097% change

6/30/2026

Vanguard Portfolio Management Llc

6,228,614 shares

1.057% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 21:50 UTC· 1 day ago

Research coverage and investment tools

The Cigna Group (CI) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$306.60 on 20 Oct 2026. That is 93% of the way from its 52-week low of US$239.51 to its 52-week high of US$311.34. It paid US$6.19 a share in dividends over the last 12 months, a dividend yield of 2.02%. The latest ex-dividend date on file is 8 Sep 2026. Its market capitalisation was US$81.02 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$71.67B	$2.68B	$1.66B	$6.29	—	3.7%	—	10-Q · 30 Jul 2026 (opens in a new tab)
Q1 2026	$68.49B	$2.36B	$1.65B	$6.26	—	3.4%	—	10-Q · 30 Apr 2026 (opens in a new tab)
Q4 2025	$72.47B	$2.35B	$943.00M	Unavailable	—	3.2%	—	10-K · 26 Feb 2026 (opens in a new tab)
Q3 2025	$69.75B	$2.58B	$1.97B	$6.98	—	3.7%	—	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$67.18B	$2.31B	$1.63B	$5.71	—	3.4%	—	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$65.50B	$1.97B	$1.41B	$4.85	—	3.0%	—	10-Q · 2 May 2025 (opens in a new tab)

Cash and equivalents: $6.30B
Total assets: $157.08B
Total liabilities: $114.17B
Shareholders' equity: $42.62B
Long-term debt: $39.52B
Debt due within a year: $2.79B

8-K · 10 Oct 2026 · Management change

The Cigna Group reported A director or senior management change or compensation event (opens in a new tab)

The Cigna Group filed an 8-K covering a director or senior management change or compensation event.
8-K · 30 Sep 2026

The Cigna Group reported Regulation FD disclosure (opens in a new tab)

The Cigna Group filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
10-Q · 30 Jul 2026

The Cigna Group filed Form 10-Q (opens in a new tab)

The Cigna Group submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 30 Jul 2026

The Cigna Group reported Operating or financial results (opens in a new tab)

The Cigna Group filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 13 May 2026

The Cigna Group reported Regulation FD disclosure (opens in a new tab)

The Cigna Group filed an 8-K covering Regulation FD disclosure.

Insider	Date	Transaction	Shares	Average price	Filing
Neville Everett See Remarks	3 Sep 2026	Open-market sale (S)	−617	$284.05	Form 4 (opens in a new tab)
Evanko Brian C See Remarks	1 Sep 2026	Grant or award (A)	+3,113	—	Form 4 (opens in a new tab)
Jones Nicole S See Remarks	18 Aug 2026	Open-market sale (S)	−2,677	$279.61	Form 4 (opens in a new tab)
Jones Nicole S See Remarks	5 Aug 2026	Option exercise (M)	+1,301	$192.02	Form 4 (opens in a new tab)
Jones Nicole S See Remarks	4 Aug 2026	Option exercise (M)	+14,045	$192.02	Form 4 (opens in a new tab)
Jones Nicole S See Remarks	4 Aug 2026	Open-market sale (S)	−19,436	$276.27	Form 4 (opens in a new tab)
Kates Jamie G Chief Accounting Officer	12 Jun 2026	Option exercise (M)	+899	$152.89	Form 4 (opens in a new tab)
Kates Jamie G Chief Accounting Officer	12 Jun 2026	Open-market sale (S)	−899	$298.61	Form 4 (opens in a new tab)
Koka Durga Prasad EVP, Global CIO	1 Jun 2026	Tax withholding (F)	−729	$275.53	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	26,173,577	1.61%
Blackrock, Inc.	6/30/2026	23,438,250	3.718%
Vanguard Capital Management Llc	6/30/2026	17,276,296	0.901%
State Street Corp	6/30/2026	12,682,259	3.249%
Dodge & Cox	6/30/2026	12,173,875	5.349%
Massachusetts Financial Services Co /Ma/	6/30/2026	10,443,691	-9.931%
Sanders Capital, Llc	6/30/2026	10,144,617	-1.417%
Fmr Llc	6/30/2026	8,018,189	-26.823%
Geode Capital Management, Llc	6/30/2026	6,268,347	1.097%
Vanguard Portfolio Management Llc	6/30/2026	6,228,614	1.057%

Previous close: 298.50 USD
Day range: 300.86 – 307.00 USD
52-week range: 239.51 – 311.34 USD
Volume: 1,440,321
Market cap: $81.02B
Average volume: 1,875,538
P/E ratio: 13.0
EPS (FY 2025, diluted): 22.18 USD
Dividends (last 12 months): 6.19 USD
Dividend yield: 2.02%
Ex-dividend date: 8 Sep 2026
Shares outstanding: 264.24M
Beta (5Y monthly): 0.25

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:08 UTC· 1 hour ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 08:08 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for CI yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.